Close

Ionis Pharma (IONS) Submission of MAA for Inotersen to EMA

November 3, 2017 8:38 AM EDT Send to a Friend
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that the company submitted a marketing authorization application (MAA) to the European ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login